BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|October 1, 2005
- Volume 0 0
Pharmacy Tour Reaches Communities
Advertisement
McKesson Corp's Health AcrossAmerica: Keeping Pharmacy Care Personal23-city bus tour was a success.The tour's purpose was to raise awarenessof the vital role community pharmacistsplay in the health of Americans.Here are highlights from the tour:
- The tour gathered 68,238 signaturesfor the "Keeping PharmacyCare Personal Petition;" the petitionis to demonstrate to policymakers the need to preserve everyindividual's access to communitypharmacists
- More than 3500 community pharmacistsreceived Pharmacy AdvocacyToolkits to help promotetheir value in their communities
- 830 participants took advantageof the free health screenings
- Nominations from the NationalCommunity Pharmacists Associationand the American PharmacistsAssociation resulted in a total of$23,000 in scholarships beingawarded to 28 pharmacy students
Articles in this issue
about 21 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsabout 21 years ago
Dangerous Liaisons: Schizophrenia and Diabetesabout 21 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplementsabout 21 years ago
Tarceva Extends Lung Cancer Survivalabout 21 years ago
Inhaled Morphine Aids Cancer-related Dyspneaabout 21 years ago
Diuretic Best BP Therapy for African Americansabout 21 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsabout 21 years ago
New Drug Blocks Out AIDS Virusabout 21 years ago
Viagra Ingredient Has Another Useabout 21 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIAAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
What the 2025-2030 Dietary Guidelines Mean for Heart Health
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
5